Reduced IL-33 plasma levels in aplastic anemia.

about

IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model.Expression of CXCR4 on T-cell subsets and Plasma IL-17 Concentrations in Patients with Aplastic Anaemia.

P2860

Q40120480-3C43E2FA-DFAE-463F-9561-D050E1D10289 Q41489911-3C9E5810-C220-448E-A227-7390513A3EA9

P2860

Reduced IL-33 plasma levels in aplastic anemia.

Item

http://www.wikidata.org/entity/Q42607304

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reduced IL-33 plasma levels in aplastic anemia.

@en

Reduced IL-33 plasma levels in aplastic anemia.

@nl

type

Item

label

Reduced IL-33 plasma levels in aplastic anemia.

@en

Reduced IL-33 plasma levels in aplastic anemia.

@nl

prefLabel

Reduced IL-33 plasma levels in aplastic anemia.

@en

Reduced IL-33 plasma levels in aplastic anemia.

@nl

P1476

Reduced IL-33 plasma levels in aplastic anemia.

@en

P2093

Hai-Feng Ma

http://www.w3.org/2001/XMLSchema#string

Ming Sun

http://www.w3.org/2001/XMLSchema#string

Xin Cui

http://www.w3.org/2001/XMLSchema#string

Ye-Yun Che

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes

Current concepts in the pathophysiology and treatment of aplastic anemia

IL-33 is a crucial amplifier of innate rather than acquired immunity

Th17 immune responses contribute to the pathophysiology of aplastic anemia.

Targeting the IL17 pathway for the prevention of graft-versus-host disease.

A role for soluble ST2 in vascular remodeling associated with obesity in rats.

Aplastic anaemia.

IL-33 exacerbates antigen-induced arthritis by activating mast cells.

IL-1, IL-18, and IL-33 families of cytokines.

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

P2888

s12935-015-0270-5

P304

118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-015-0270-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287123494

http://www.w3.org/2001/XMLSchema#string

P6179

1042075028

http://www.w3.org/2001/XMLSchema#string

P698

26677348

http://www.w3.org/2001/XMLSchema#string

P932

4681025

http://www.w3.org/2001/XMLSchema#string

Reduced IL-33 plasma levels in aplastic anemia.

about

P2860

P2860

Reduced IL-33 plasma levels in aplastic anemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932